These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10683756)

  • 1. Lack of effect of dietary chromium supplementation on glucose tolerance, plasma insulin and lipoprotein levels in patients with type 2 diabetes.
    Trow LG; Lewis J; Greenwood RH; Sampson MJ; Self KA; Crews HM; Fairweather-Tait SJ
    Int J Vitam Nutr Res; 2000 Jan; 70(1):14-8. PubMed ID: 10683756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chromium supplementation on blood glucose and lipid levels in type 2 diabetes mellitus elderly patients.
    Rabinovitz H; Friedensohn A; Leibovitz A; Gabay G; Rocas C; Habot B
    Int J Vitam Nutr Res; 2004 May; 74(3):178-82. PubMed ID: 15296075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of metformin on glucose, insulin and lipid metabolism in patients with mild hypertriglyceridaemia and non-insulin dependent diabetes by glucose tolerance test criteria.
    Hollenbeck CB; Johnston P; Varasteh BB; Chen YD; Reaven GM
    Diabete Metab; 1991; 17(5):483-9. PubMed ID: 1752350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary chromium tripicolinate supplementation reduces glucose concentrations and improves glucose tolerance in normal-weight cats.
    Appleton DJ; Rand JS; Sunvold GD; Priest J
    J Feline Med Surg; 2002 Mar; 4(1):13-25. PubMed ID: 11869052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromium yeast supplementation improves fasting plasma glucose and LDL-cholesterol in streptozotocin-induced diabetic rats.
    Lai MH; Chen YY; Cheng HH
    Int J Vitam Nutr Res; 2006 Nov; 76(6):391-7. PubMed ID: 17607959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes.
    Bahijiri SM; Mira SA; Mufti AM; Ajabnoor MA
    Saudi Med J; 2000 Sep; 21(9):831-7. PubMed ID: 11376359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of chromium nicotinic acid supplementation on selected cardiovascular disease risk factors.
    Thomas VL; Gropper SS
    Biol Trace Elem Res; 1996 Dec; 55(3):297-305. PubMed ID: 9096856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
    Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
    Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biomimetic [Cr(3)O(O(2)CCH(2)CH(3))(6)(H(2)O)(3)](+ )decreases plasma insulin, cholesterol, and triglycerides in healthy and type II diabetic rats but not type I diabetic rats.
    Sun Y; Clodfelder BJ; Shute AA; Irvin T; Vincent JB
    J Biol Inorg Chem; 2002 Sep; 7(7-8):852-62. PubMed ID: 12203022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J; James RW; Makoundou V; Bioletto S; Golay A
    Diabetes Metab; 2001 Dec; 27(6):701-8. PubMed ID: 11852380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy.
    Abdin AA; Hassanien MA; Ibrahim EA; El-Noeman Sel-D
    J Diabetes Complications; 2010; 24(5):325-33. PubMed ID: 19553142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chromium supplementation on glucose tolerance and lipid profile.
    Bahijri SM
    Saudi Med J; 2000 Jan; 21(1):45-50. PubMed ID: 11533750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chromium chloride supplementation on glucose tolerance and serum lipids including high-density lipoprotein of adult men.
    Riales R; Albrink MJ
    Am J Clin Nutr; 1981 Dec; 34(12):2670-8. PubMed ID: 7032273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
    Mostad IL; Bjerve KS; Lydersen S; Grill V
    Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of diet differing in fat, carbohydrate, and fiber on carbohydrate and lipid metabolism in type II diabetes.
    O'Dea K; Traianedes K; Ireland P; Niall M; Sadler J; Hopper J; De Luise M
    J Am Diet Assoc; 1989 Aug; 89(8):1076-86. PubMed ID: 2547860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of chromium chloride-containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.
    Pei D; Hsieh CH; Hung YJ; Li JC; Lee CH; Kuo SW
    Metabolism; 2006 Jul; 55(7):923-7. PubMed ID: 16784965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of inorganic chromium supplementation on glucose tolerance, insulin response, and serum lipids in noninsulin-dependent diabetics.
    Uusitupa MI; Kumpulainen JT; Voutilainen E; Hersio K; Sarlund H; Pyörälä KP; Koivistoinen PE; Lehto JT
    Am J Clin Nutr; 1983 Sep; 38(3):404-10. PubMed ID: 6351586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chromium-enriched yeast on fasting plasma glucose, glycated haemoglobin and serum lipid levels in patients with type 2 diabetes mellitus treated with insulin.
    Racek J; Sindberg CD; Moesgaard S; Mainz J; Fabry J; Müller L; Rácová K
    Biol Trace Elem Res; 2013 Oct; 155(1):1-4. PubMed ID: 23921483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dietary phytosphingosine on cholesterol levels and insulin sensitivity in subjects with the metabolic syndrome.
    Snel M; Sleddering MA; Pijl H; Nieuwenhuizen WF; Frölich M; Havekes LM; Romijn JA; Jazet IM
    Eur J Clin Nutr; 2010 Apr; 64(4):419-23. PubMed ID: 20179727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.